[1]吕震,唐乾利,卓臣义,等.大黄灵仙方对腹腔镜胆总管切开取石疗效的影响[J].西部中医药,2023,36(05):90-93.[doi:10.12174/j.issn.2096-9600.2023.05.20]
 LYU Zhen,TANG Qianli,ZHUO Chenyi,et al.Influence of Dahuang Lingxian Prescription on Clinical Effects of Laparoscopic Choledochotomy Lithotomy[J].Western Journal of Traditional Chinese Medicine,2023,36(05):90-93.[doi:10.12174/j.issn.2096-9600.2023.05.20]
点击复制

大黄灵仙方对腹腔镜胆总管切开取石疗效的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年05期
页码:
90-93
栏目:
出版日期:
2023-05-15

文章信息/Info

Title:
Influence of Dahuang Lingxian Prescription on Clinical Effects of Laparoscopic Choledochotomy Lithotomy
作者:
吕震1, 唐乾利2, 卓臣义2, 葛斌2, 俞渊3, 王兵3, 冯时2, 许彦3
1.浙江省诸暨市中医医院,浙江 诸暨 311800
2.右江民族医学院/广西肝胆疾病临床医学研究中心,广西 百色 533000
3.广西中医药大学第一附属医院,广西 南宁 530023
Author(s):
LYU Zhen1, TANG Qianli2, ZHUO Chenyi2, GE Bin2, YU Yuan3, WANG Bing3, FENG Shi2, XU Yan3
1.Traditional Chinese Medical Hospital of Zhuji, Zhuji 311800, China
2.Youjiang Medical University for Nationalites/Guangxi Clinical Medical Research Center for Hepatobiliary Diseases, Baise 533000, China
3.the First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China
关键词:
胆总管结石腹腔镜大黄灵仙方临床疗效
Keywords:
choledocholithiasislaparoscopeprescriptionclinical effects
分类号:
R256.49
DOI:
10.12174/j.issn.2096-9600.2023.05.20
文献标志码:
B
摘要:
目的探讨大黄灵仙方对腹腔镜下胆总管切开取石术疗效的影响。 方法将67例胆总管结石患者随机分为治疗组34例和对照组33例。两组患者均行腹腔镜下胆总管切开取石术,术后除常规治疗外,治疗组加服大黄灵仙方汤剂。观察两组患者T管胆汁引流量、术后禁食与肛门排气时间及并发症发生情况;比较两组患者排石率、总有效率及术后复发率。 结果总有效率治疗组为97.05%(33/34),高于对照组的81.82%(27/33)(P=0.041);术后第4天治疗组患者T管引流量为(374.20±90.80)mL,多于对照组的(326.86±68.40)mL(P=0.019);排石率治疗组为80.00%(8/10),高于对照组的33.33%(3/9)(P=0.04);复发率治疗组为3.13%(1/32),低于对照组的22.22%(6/27)(P=0.024);谷丙转氨酶、谷草转氨酶、总胆红素、碱性磷酸酶、γ-谷氨酰转移酶治疗组分别为(55.20±18.63)U/L、(51.32±15.12)U/L、(23.34±9.73)μmol/L、(103.87±40.84)U/L、(56.82±19.38)U/L,分别低于对照组的(67.89±20.65)U/L(P=0.010)、(60.72±17.8)U/L(P=0.023)、(28.66±10.50)μmol/L(P=0.035)、(129.22±49.23)U/L(P=0.025)、(63.13±21.47)U/L(P=0.211);术后肛门排气时间、禁食时间及住院时间治疗组均短于对照组(P<0.05);并发症发生率两组比较差异无统计学意义(P=0.261)。 结论大黄灵仙方具有促进腹腔镜下胆总管切开取石术患者胆汁排泄、减轻胆管炎症水肿、减少胆道感染几率、改善肝细胞代谢、促进胃肠功能恢复、防治结石复发等作用。
Abstract:
ObjectiveTo discuss the influence of Dahuang Lingxian prescription on clinical efficacy of laparoscopic choledochotomy lithotomy. MethodsAll 67 patients were randomized into 34 cases of the treatment group and 33 cases of the control group. The patients in both groups performed laparoscopic choledochotomy lithotomy, besides postoperative routine therapy, the treatment group was treated with Dahuang Lingxian decoction. To observe the T-duct bile drainage flow rate, postoperative fasting and anal exhaust time and the incidence of the complications between both groups; to compare stone discharge rate, total effective rate and the recurrence rate after the surgery between both groups. ResultsTotal effective rate of the treatment group was 97.05% (33/34), higher than 81.82% (27/33) of the control group (P=0.041); the patients' T-duct bile drainage volume was (374.20±90.80)mL in the treatment group the forth day after the surgery, higher than (326.86±68.40)mL in the control group (P=0.019); stone discharge rate of the treatment group was 80.00% (8/10), higher than 33.33%(3/9) of the control group (P=0.04); the recurrence rate of the treatment group was 3.13% (1/32), lower than 22.22% (6/27) of the control group (P=0.024); the concentrations of ALT, AST, TBIL and ALP γ-glutamyl transferase (γ-GT) of the treatment group were (55.20±18.63)U/L, (51.32±15.12)U/L, (23.34±9.73)μmol/L and (103.87±40.84)U/L,(56.82±19.38)U/L respectively, lower than (67.89±20.65)U/L (P=0.010), (60.72±17.8)U/L (P=0.023), (28.66± 10.50)μmol/L (P=0.035), and (129.22±49.23)U/L (P=0.025), (63.13±21.47)U/L (P=0.211); postoperative anal exhaust time fasting time and hospital stay of the treatment group were shorter than these of the control group (P<0.05); the difference had no statistical meaning in the incidence of the complications between both groups (P=0.261). ConclusionDahuang Lingxian prescription could promote bile excretion, relieve the edema and inflammation of bile duct, reduce the odds of biliary infection, improve the metabolism of liver cells, promote the recovery of gastrointestinal function and prevent the stone recurrence.

相似文献/References:

[1]田 莉,丁晓华,何文华,等.中药足浴联合艾灸预防妇科腹腔镜术后腹胀的临床研究[J].西部中医药,2012,25(07):94.
 TIAN Li,DING Xiao-hua,HE Wen-hua,et al.Clinical Study on Lavipeditum Combined with Moxibustion in Preventing Abdominal Distention after Laparoscopic Surgery[J].Western Journal of Traditional Chinese Medicine,2012,25(05):94.
[2]杨闯,张永川,古广强,等.利胆排石汤联合纤维十二指肠镜治疗胆总管结石40例临床观察[J].西部中医药,2013,26(08):40.
 YANG Chuang,ZHANG Yongchuan,GU Guangqiang,et al.Clinical Observation on LiDan PaiShiTang and Duodenofiberscope in Treating 40 Cases of Choledocholithiasis[J].Western Journal of Traditional Chinese Medicine,2013,26(05):40.
[3]李巧梅,刘洁.十二指肠镜联合钬激光、中药治疗肝内外胆管结石的临床观察[J].西部中医药,2012,25(09):64.
 LI Qiao-mei,LIU Jie.Duodenoscope, Holmium-Laser and Herbs in Treating Hepatic & Extra-hepatic Bile Duct Stones[J].Western Journal of Traditional Chinese Medicine,2012,25(05):64.
[4]巫资明,李初谊.三镜联合茵陈蒿汤治疗梗阻性黄疸80例[J].西部中医药,2013,26(08):94.
 WU Ziming,LI Chuyi.Treatment for 80 Cases of Obstructive Jaundice with YinChenHaoTang and Three Kinds of Endoscopes[J].Western Journal of Traditional Chinese Medicine,2013,26(05):94.
[5]裴永胜.疏肝利胆汤联合腹腔镜治疗急性结石性胆囊炎 30 例[J].西部中医药,2014,27(08):103.
[6]石启彩,刘凤侠,孙动梅.循证护理在腹腔镜治疗卵巢囊肿蒂扭转中的应用[J].西部中医药,2014,27(11):145.
[7]李璐璐,黄晓俊△,肖吉元,等.两种剂量排石汤治疗胆总管结石ERCP术后患者的临床研究[J].西部中医药,2019,32(02):101.
 LI Lulu,HUANG Xiaojun,XIAO Jiyuan,et al.Clinical Study on Two Different Dosages of Modified PaiShi Decoction or Choledocholith Patients after ERCP[J].Western Journal of Traditional Chinese Medicine,2019,32(05):101.
[8]陆芸,施华△.“生物-心理-社会”整体化护理对腹腔镜下子宫内膜异位症手术患者负性情绪的影响[J].西部中医药,2019,32(05):123.
 LU Yun,SHI Hua.Influence of ″Biological-Psychological-Social″ Holistic Nursing on Negative Emotion of Endometriosis Patients Undergoing Laparoscopic Surgery[J].Western Journal of Traditional Chinese Medicine,2019,32(05):123.
[9]李春英.调经消异汤对子宫内膜异位症术后患者的影响[J].西部中医药,2020,33(08):93.[doi:10.12174/j.issn.1004-6852.2020.08.24]
 LI Chunying.Effects of Period-regulating Endometriosis-eliminating Decoction on Patients After the Surgery of Endometriosis[J].Western Journal of Traditional Chinese Medicine,2020,33(05):93.[doi:10.12174/j.issn.1004-6852.2020.08.24]

备注/Memo

备注/Memo:
吕震(1989—),男,硕士学位,主治中医师。研究方向:中西医结合外科学。国家自然科学基金(81860851);广西科学研究与技术开发计划项目(重点研发计划)(桂科AB17195071);广西自然科学基金(2018GXNSFDA281017)。
更新日期/Last Update: 2023-05-15